Ka-Hang Fok

Title: The Innovative Contributions of Inventor Ka-Hang Fok

Introduction: Ka-Hang Fok is a distinguished inventor based in Taipei Hsien, Taiwan, recognized for his significant contributions to the field of biotechnology. He has been at the forefront of innovative research, particularly in the area of cancer treatment.

Latest Patents: Fok is credited with one notable patent, which focuses on a novel compound isolated and purified from Antrodia camphorate. This patent describes a compound known as 4-hydroxy-2,3-dimethoxy-6-methyl-5(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone. This unique compound has shown promising potential for inhibiting tumor growth, especially in cancers such as breast, hepatic, and prostate cancers. The invention also suggests applications in the prevention of heart and blood vessel diseases, as well as its use as a dietary supplement due to its antioxidant properties.

Career Highlights: Fok works for Golden Biotechnology Corporation, where he has harnessed his expertise to develop and explore innovative pharmaceutical solutions. His work not only addresses pressing health issues but also reflects the company's commitment to advancing biotechnological research.

Collaborations: Throughout his career, Fok has collaborated with esteemed colleagues like Sheng-Yun Liu and Wu-Che Wen. These partnerships emphasize the importance of teamwork in driving innovation and achieving breakthroughs in medical research.

Conclusion: Ka-Hang Fok stands out as an influential figure in the realm of biotechnology, with a patent that holds promise for significant advancements in cancer treatment and health. His commitment to research and collaboration highlights the vital role inventors play in the ongoing quest for innovative medical solutions.